W Paul Dmowski
Overview
Explore the profile of W Paul Dmowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
390
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carr B, Giudice L, Dmowski W, OBrien C, Jiang P, Burke J, et al.
J Endometr Pelvic Pain Disord
. 2018 Oct;
5(3):105-115.
PMID: 30320043
Objective: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. Methods: This was a...
2.
Surrey E, Taylor H, Giudice L, Lessey B, Abrao M, Archer D, et al.
Obstet Gynecol
. 2018 Jun;
132(1):147-160.
PMID: 29889764
Objective: To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain. Methods: Elaris Endometriosis (EM)-III and -IV were...
3.
Taylor H, Giudice L, Lessey B, Abrao M, Kotarski J, Archer D, et al.
N Engl J Med
. 2017 May;
377(1):28-40.
PMID: 28525302
Background: Endometriosis is a chronic, estrogen-dependent condition that causes dysmenorrhea and pelvic pain. Elagolix, an oral, nonpeptide, gonadotropin-releasing hormone (GnRH) antagonist, produced partial to nearly full estrogen suppression in previous...
4.
Carr B, Dmowski W, OBrien C, Jiang P, Burke J, Jimenez R, et al.
Reprod Sci
. 2014 Sep;
21(11):1341-51.
PMID: 25249568
This randomized double-blind study, with 24-week treatment and 24-week posttreatment periods, evaluated the effects of elagolix (150 mg every day, 75 mg twice a day) versus subcutaneous depot medroxyprogesterone acetate...
5.
Diamond M, Carr B, Dmowski W, Koltun W, OBrien C, Jiang P, et al.
Reprod Sci
. 2013 Jul;
21(3):363-71.
PMID: 23885105
This Phase 2 study evaluated the safety and efficacy of elagolix for treating endometriosis-associated pain. A total of 155 women with laparoscopically confirmed endometriosis were randomized to placebo, elagolix 150...
6.
Ding J, Rana N, Dmowski W
J Reprod Med
. 2008 Nov;
53(10):813-20.
PMID: 19004412
Background: The technology for successful oocyte cryopreservation has evolved only over the past decade. Fewer than 300 pregnancies achieved with cryopreserved oocytes were reported as of the end of 2006....
7.
Xu X, Ding J, Ding H, Shen J, Gattuso P, Prinz R, et al.
Fertil Steril
. 2007 May;
88(5):1304-10.
PMID: 17481627
Objective: To investigate the expression of heparanase-1, an endoglycosidase that degrades heparan sulfate proteoglycans, in eutopic and ectopic endometrial tissues from women with endometriosis. Design: An immunohistochemical study. Setting: Academic...
8.
Xu X, Ding J, Rao G, Shen J, Prinz R, Rana N, et al.
Hum Reprod
. 2007 Jan;
22(4):927-37.
PMID: 17261577
Background: This study seeks to determine whether estrogen is able to regulate the expression of heparanase-1 (HPR1) in human endometrium. Methods: HPR1 expression and heparan sulphate (HS) deposition in the...
9.
Braun D, Ding J, Shaheen F, Willey J, Rana N, Dmowski W
Fertil Steril
. 2006 Nov;
87(2):263-8.
PMID: 17094974
Objective: To quantitate antiapoptotic and proapoptotic gene expression in endometrial cells (ECs) of women with and without endometriosis. Design: Determination of transcript abundance (TA) of apoptosis-regulating genes in eutopic and...
10.
Ding J, Pry M, Rana N, Dmowski W
J Assist Reprod Genet
. 2004 Nov;
21(6):203-10.
PMID: 15526975
Purpose: To compare the effects of two different blastocyst thawing protocols on implantation, pregnancy, and live birth rates. Methods: Ninety four consecutive frozen-thawed blastocyst transfers from 1996 to 2002 were...